JP2011530514A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530514A5
JP2011530514A5 JP2011522119A JP2011522119A JP2011530514A5 JP 2011530514 A5 JP2011530514 A5 JP 2011530514A5 JP 2011522119 A JP2011522119 A JP 2011522119A JP 2011522119 A JP2011522119 A JP 2011522119A JP 2011530514 A5 JP2011530514 A5 JP 2011530514A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
nos
acid sequences
sequences shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522119A
Other languages
English (en)
Japanese (ja)
Other versions
JP5730200B2 (ja
JP2011530514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/052044 external-priority patent/WO2010017070A1/en
Publication of JP2011530514A publication Critical patent/JP2011530514A/ja
Publication of JP2011530514A5 publication Critical patent/JP2011530514A5/ja
Application granted granted Critical
Publication of JP5730200B2 publication Critical patent/JP5730200B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522119A 2008-08-06 2009-07-29 抗ヘプシジン−25選択的抗体およびその使用 Expired - Fee Related JP5730200B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8655708P 2008-08-06 2008-08-06
US61/086,557 2008-08-06
PCT/US2009/052044 WO2010017070A1 (en) 2008-08-06 2009-07-29 Anti-hepcidin-25 selective antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2011530514A JP2011530514A (ja) 2011-12-22
JP2011530514A5 true JP2011530514A5 (enExample) 2013-06-06
JP5730200B2 JP5730200B2 (ja) 2015-06-03

Family

ID=41165490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522119A Expired - Fee Related JP5730200B2 (ja) 2008-08-06 2009-07-29 抗ヘプシジン−25選択的抗体およびその使用

Country Status (19)

Country Link
US (1) US8609817B2 (enExample)
EP (1) EP2328931B1 (enExample)
JP (1) JP5730200B2 (enExample)
KR (1) KR101462307B1 (enExample)
CN (1) CN102112489B (enExample)
AU (1) AU2009279865B2 (enExample)
BR (1) BRPI0916624A2 (enExample)
CA (1) CA2733497C (enExample)
DK (1) DK2328931T3 (enExample)
EA (1) EA201170312A1 (enExample)
ES (1) ES2432018T3 (enExample)
IL (1) IL210643A (enExample)
MX (1) MX2011001363A (enExample)
NZ (1) NZ590863A (enExample)
PL (1) PL2328931T3 (enExample)
PT (1) PT2328931E (enExample)
UA (1) UA103032C2 (enExample)
WO (1) WO2010017070A1 (enExample)
ZA (1) ZA201100261B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336176B1 (en) * 2003-04-01 2015-05-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes
AR069062A1 (es) * 2007-11-02 2009-12-23 Lilly Co Eli Anticuerpo anti-hepcidina
CA2808392C (en) 2010-08-16 2020-03-10 Pieris Ag Binding proteins for hepcidin
US9610356B2 (en) 2011-12-12 2017-04-04 Pieris Pharmaceutical GmbH Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
US10316103B1 (en) 2012-03-30 2019-06-11 Biocare Medical, Llc Systems and methods for anti-Uroplakin III antibodies
US20140120560A1 (en) * 2012-10-26 2014-05-01 Claresa Levetan Generation of new pancreatic beta cells
US10429390B2 (en) 2012-12-18 2019-10-01 Biocare Medical, Llc Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer
DK2968503T3 (en) * 2013-03-15 2018-12-03 Intrinsic Lifesciences Llc ANTI-HEPCIDIN ANTIBODIES AND APPLICATIONS THEREOF
DK3052522T3 (da) * 2013-10-03 2020-02-24 Biocare Medical Llc Anti-sox 10 antistofsystemer og -fremgangsmåder
WO2016027469A1 (ja) * 2014-08-21 2016-02-25 国立大学法人旭川医科大学 ヘプシジンのスプライシングバリアント並びに該バリアントを指標とした癌の診断方法
EP3197915A4 (en) * 2014-09-22 2018-12-19 Intrinsic Lifesciences LLC Humanized anti-hepcidin antibodies and uses thereof
EP3268027B1 (en) 2015-03-13 2022-11-02 Institut National de la Santé et de la Recherche Médicale (INSERM) Hepcidin antagonists for use in the treatment of inflammation
WO2018063963A1 (en) * 2016-09-28 2018-04-05 Board Of Regents, The University Of Texas System Antibody and protein therapeutic formulations and uses thereof
EA201991204A1 (ru) 2016-12-22 2019-12-30 Университа Дельи Студи Манья Греча Катандзаро Моноклональное антитело против уникального сиалогликозилированного опухолеассоциированного эпитопа cd43
WO2018234538A1 (en) 2017-06-23 2018-12-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Hepcidin antagonist or agonist for use in the treatment of dysregulation of mo and/or mn metabolism
CN109948371B (zh) * 2019-03-07 2021-06-25 深圳市智税链科技有限公司 为区块链节点发放身份证书的方法及相关装置
KR20220088699A (ko) 2019-09-27 2022-06-28 디스크 메디슨, 인크. 골수섬유증 및 관련 상태의 치료 방법
KR20230012539A (ko) 2020-05-13 2023-01-26 디스크 메디슨, 인크. 골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
WO2022098812A1 (en) 2020-11-04 2022-05-12 Keros Therapeutics, Inc. Methods of treating iron overload
JPWO2022154121A1 (enExample) * 2021-01-18 2022-07-21

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004522402A (ja) 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
US6262247B1 (en) 1999-08-30 2001-07-17 Incyte Genomics, Inc. Polycyclic aromatic hydrocarbon induced molecules
CA2448382C (en) * 2001-05-25 2013-02-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of hepcidin as a regulator of iron homeostasis
CN1173737C (zh) 2002-10-21 2004-11-03 钱忠明 Hepcidin(海魄喜定)在制药中的应用
US8017737B2 (en) * 2002-11-19 2011-09-13 Hasan Kulaksiz Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor
EP1578254B1 (en) 2002-11-19 2013-03-06 DRG International, Inc. Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
US7411048B2 (en) * 2002-11-19 2008-08-12 Drg International, Inc. Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids
US20050033029A1 (en) 2003-06-30 2005-02-10 Jin Lu Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
EP1673465A4 (en) 2003-09-29 2008-04-30 Biosite Inc PROCESS AND COMPOSITIONS FOR SEPSIS DIAGNOSIS
AU2003271174A1 (en) * 2003-10-10 2005-04-27 Chugai Seiyaku Kabushiki Kaisha Double specific antibodies substituting for functional protein
US7723063B2 (en) * 2004-04-28 2010-05-25 Intrinsic Lifesciences Methods for measuring levels of bioactive human hepcidin
NZ560976A (en) * 2005-03-11 2011-06-30 Univ Johns Hopkins Biomarkers for ovarian cancer and endometrial cancer: hepcidin
PE20090722A1 (es) 2007-02-02 2009-07-13 Amgen Inc Hepcidina, antagonistas de la hepcidina y metodos de uso
GR1006896B (el) 2007-08-24 2010-07-20 Ελληνικο Ινστιτουτο Παστερ, Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
ATE553778T1 (de) * 2007-10-02 2012-05-15 Inst Nat Sante Rech Med Für humanes hepcidin spezifische antikörper
AR069062A1 (es) * 2007-11-02 2009-12-23 Lilly Co Eli Anticuerpo anti-hepcidina
EP2816059A1 (en) 2008-05-01 2014-12-24 Amgen, Inc Anti-hepcidin antibodies and methods of use

Similar Documents

Publication Publication Date Title
JP2011530514A5 (enExample)
CA2733497C (en) Anti-hepcidin-25 selective antibodies and uses thereof
KR101669918B1 (ko) 사람 체액 중의 시스타틴 c의 측정방법
RU2010117018A (ru) Антитела к gdf8 и их применения
RU2014146707A (ru) Антитела против тофацитиниба и их применение для лекарственного мониторинга
JP6129956B2 (ja) 抗c−Met抗体
JPWO2007114337A1 (ja) 免疫凝集反応試薬キット及び抗原の測定方法
JP6873995B2 (ja) ヘプシジンの検出用キット
CN117624367B (zh) 抗人cd141蛋白的兔单克隆抗体及其应用
CN104142406B (zh) 一种稳定的肌钙蛋白i检测试剂盒
WO2023013764A1 (ja) 非アルコール性脂肪性肝炎における線維化進行度および/または前記肝疾患の活動性を推定する方法
WO2017132062A1 (en) Cgrp antibodies and uses thereof
CN120192412B (zh) 抗T3抗体mAb32或抗原结合片段、制备方法和应用
CN120040588B (zh) 抗T3抗体mAb68或抗原结合片段、制备方法和应用
KR20210073785A (ko) 호산구 유래 신경독과 특이적으로 결합하는 단일클론항체 및 이의 용도
JP7207517B2 (ja) App669-711の測定方法、及び測定用キット
JP7715637B2 (ja) 免疫反応を利用したアナライトの測定方法及び測定試薬
RU2010149317A (ru) Способ количественного определения специфических иммуноглобулинов g к низкомолекулярным соединениям в сыворотке крови
CN102597772B (zh) 5.9kDa肽的免疫学测定方法
JP4505800B2 (ja) 抗腎タイプivモノクロ−ナル抗体
RU2023100156A (ru) Диагностические анализы и наборы для детекции фолатного рецептора 1
JP2005298395A (ja) 抗重金属モノクローナル抗体およびその使用方法
HK1156326B (en) Anti-hepcidin-25 selective antibodies and uses thereof
WO2014073653A1 (ja) 腎炎の病変部位の検査方法およびそのための試薬